Ask AI

From Podium to Practice: Experts Discuss Their Current and Future Management of RCC

Gain a deeper understanding of how to optimize first-line and subsequent-line treatments for renal cell carcinoma (RCC), including targeted and immunotherapy-based regimens, based on the latest practice-changing data and expert recommendations through downloadable slides.

Share

Program Content

Events

Activities

Emerging Data and Management of Renal Cell Carcinoma
Emerging Data and Management of Renal Cell Carcinoma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 17, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AVEO Pharmaceuticals, Inc. and Eisai.

AVEO Pharmaceuticals, Inc.

Eisai